|
|
|
|
| LEADER |
01545nam a2200301 u 4500 |
| 001 |
EB002000544 |
| 003 |
EBX01000000000000001163445 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Medications for opioid use disorder
|h Elektronische Ressource
|b for healthcare and addiction professionals, policymakers, patients, and families
|
| 260 |
|
|
|a [Rockville, Maryland]
|b U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment
|c 2018, [2018]
|
| 300 |
|
|
|a 1 PDF file (various pagings)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Opiate Substitution Treatment
|
| 653 |
|
|
|a Counseling / methods
|
| 653 |
|
|
|a Naltrexone / administration & dosage
|
| 653 |
|
|
|a Opioid-Related Disorders / drug therapy
|
| 653 |
|
|
|a Methadone / administration & dosage
|
| 653 |
|
|
|a Buprenorphine / administration & dosage
|
| 710 |
2 |
|
|a Center for Substance Abuse Treatment (U.S.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a TIP
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK535268
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment--methadone, naltrexone, and buprenorphine--and the other strategies and services needed to support people in recovery
|